Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxonidine in Vascular Surgery
NCT00244504Phase 3Terminated
- Sponsor
- University Hospital Basel
- Start
- Nov 2002
- Primary completion
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in heart disease comparing moxonidine group with placebo group (2 arms). Primary endpoint: Overall Mortality at 12 months. Started Nov 2002; status: terminated.
02
Drugs
moxonidine
03
Conditions
heart disease
Beyond the preview
Go deeper on NCT00244504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00244504.